For instance, the use of the cerebellum as a pseudo-reference region to quantify TSPO binding in Alzheimer’s disease patients was justified by histological proof that this region is largely spared from inflammatory changes occurring over the course of the disease and by previous confirmation with full kinetic modeling that its binding potential did not change in the populations under study [53]. Here, TSPO is linked to early-onset autosomal dominant Alzheimer disease.